Perrigo Announces New Date for Joint FDA Advisory Committee Meeting to Review Opill® Daily Oral Contraceptive for OTC UsePRNewsWire • 03/28/23
Perrigo to Present at Upcoming 12th Annual UBS Global Consumer and Retail ConferencePRNewsWire • 03/02/23
Perrigo Announces FDA Approval of the Store Brand OTC Equivalent of Advil® Dual Action TabletsPRNewsWire • 03/01/23
Perrigo Launches its 3-Year Optimize and Accelerate Strategic Plan, Issues Fiscal 2023 Guidance and Introduces 2025 Financial Targets at Investor DayPRNewsWire • 02/28/23
Perrigo Reports Fourth Quarter & Fiscal Year 2022 Financial Results From Continuing OperationsPRNewsWire • 02/27/23
Perrigo to Release Fourth Quarter and Fiscal Year 2022 Financial Results on February 27, 2023, Conduct Virtual Investor Day on February 28, 2023PRNewsWire • 02/14/23
SWEDEN'S SKINCARE SENSATION ACO EXTENDS PRESENCE INTO US TIMED TO THE HOLIDAY SEASONGlobeNewsWire • 12/16/22
Perrigo stock slides premarket after earnings miss as strong dollar and labor shortages weighMarket Watch • 11/08/22
Perrigo Reports Third Quarter Fiscal Year 2022 Financial Results From Continuing OperationsPRNewsWire • 11/08/22